×
ADVERTISEMENT

FEBRUARY 10, 2023

FDA Updates Ibuprofen Compounding Guidance to Address Home Use

By PPN News Staff

The FDA revised its recent guidance on compounding ibuprofen oral suspension products to boost supplies for pediatric patients. The revised guidance addresses ibuprofen dispensed for home use.

The agency issued the original guidance in response to record high demand for fever-reducing medications amid surging rates of COVID-19, respiratory syncytial virus and influenza. It describes the FDA’s regulatory and enforcement policies for compounding certain ibuprofen oral